One Lab. Vital Answers.
NeoGenomics Laboratories stands at the forefront of cancer genetics testing and information services, offering an extensive suite of oncology-focused testing options. NeoGenomics supports physicians in diagnosing and treating cancer, contributing significantly to advancements in patient care.
With its headquarters in Fort Myers, Florida, located at 9490 NeoGenomics Way, Fort Myers, Florida 33912, US, NeoGenomics operates accredited and certified laboratories ensuring high-quality sample processing. Dedicated to connecting patients with life-altering therapies and clinical trials, NeoGenomics partners with various stakeholders to improve cancer treatment outcomes.
NeoGenomics serves a diverse clientele, including pathologists, oncologists, academic centers, hospital systems, pharmaceutical firms, integrated service delivery networks, and managed care organizations across the United States and Europe. NeoGenomics is committed to innovation and excellence in the field of cancer diagnostics. We invite the manager of NeoGenomics Laboratories to create a customized and exclusive company showcase and product listing on our platform to further enhance your commercial development.
NeoGenomics Laboratories est à l'avant-garde des tests de génétique du cancer et des services d'information, offrant une gamme étendue d'options de tests axés sur l'oncologie. NeoGenomics aide les médecins à diagnostiquer et à traiter le cancer, contribuant ainsi de manière significative aux progrès des soins aux patients.
Avec son siège social à Fort Myers, en Floride, situé au 9490 NeoGenomics Way, Fort Myers, Florida 33912, US, NeoGenomics exploite des laboratoires accrédités et certifiés garantissant un traitement d'échantillons de haute qualité. Dédié à connecter les patients avec des thérapies et des essais cliniques qui changent leur vie, NeoGenomics s'associe à diverses parties prenantes pour améliorer les résultats du traitement du cancer.
NeoGenomics dessert une clientèle diversifiée, comprenant des pathologistes, des oncologues, des centres universitaires, des systèmes hospitaliers, des sociétés pharmaceutiques, des réseaux de prestation de services intégrés et des organisations de soins gérés à travers les États-Unis et l'Europe. NeoGenomics s'engage pour l'innovation et l'excellence dans le domaine du diagnostic du cancer. Nous invitons le responsable de NeoGenomics Laboratories à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin d'améliorer encore votre développement commercial.
Compare NeoGenomics Laboratories with 3 companies in Hospitals-and-Health-Care
| Comparison Field |
NeoGenomics LaboratoriesMain Company |
HematogenixView Profile |
Dorevitch PathologyView Profile |
Applied Spectral Ima...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 1993 | ||
|
Company Size
|
— | 51-200 | 1,001-5,000 | 51-200 |
|
City
|
Fort Myers, Florida | Tinley Park, IL | Heidelberg, Victoria | Carlsbad, CA |
|
Country
|
United States | United States | ||
|
Skills & Keywords
Comparing with main company
|
15 Total Skills
Cancer Genetics
Oncology Testing
Diagnostics
Pathology
Molecular Oncology
Pharmaceutical Research
Genetic Testing
Cytogenetics
Flow Cytometry
Fluorescence In Situ Hybridization (FISH)
Molecular Genetics
Immunohistochemistry
Pharma Research Services
Molecular Oncology & Pathology
Next-Gen Sequencing (NGS)
|
14 Total
1 Common
13 Unique
Match
7%
Common Skills:
Pathology
Unique Skills:
CAP – Accredited
CLIA – Certified
Digital Pathology
FISH
GCP – Compliant
Hematopathology
+7
|
12 Total
1 Common
11 Unique
Match
7%
Common Skills:
Pathology
Unique Skills:
Biochemistry
Cytology
Haematology
Histology
Infectious Molecular
Medical Diagnostic Testing
+5
|
12 Total
1 Common
11 Unique
Match
7%
Common Skills:
Pathology
Unique Skills:
Cancer Diagnostics
Cytopathology
Dermatopathology
fluorescence in situ Hybridization (FISH)
Hematopathology
Hyperspectral Imaging
+5
|
Other organizations in the same industry
This company is also known as